The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients

Recruiting now · Phase 4 · Has a placebo group

Conditions studied: Acute Bronchitis

In brief

Clinical Study to Evaluate the Efficacy and Safety of Atock Dry Syrup with Acute bronchial Patients

Key facts

Study ID

NCT06411925

Run by

SamA Pharmaceutical Co., Ltd

People needed

296

Starts

2023-11-10

Expected to finish

2027-09-01

Last updated by the study team

2025-09-23

Who can join

Age: 1 and older, up to 11. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children aged ≥6 months to <12 years old
• Total Bronchitis Severity Scale excluding sputum(BSSEs) ≥4
• Wheezing score ≥2
• Subjects who present symptoms of Acute Bronchitis within 48 hours from screening visit
• Subject with negative results in HbsAg or HCV Ab test within 6 months from screening visit

You may not qualify if…

• Subjects with chronic respiratory diseases (e.g., asthma, COPD) or severe respiratory diseases (e.g., pneumonia, cystic fibrosis, influenza, active tuberculosis)
• Subjects under treatment with corticosteroids, antibiotics medications
• Subjects with severe hepatic and renal impairment
• Subjects with a history of drug abuse
• Subject with positive results in HIV Ab test

Where it is running

• Soonchunhyang University Seoul Hospital — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.